{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:08:56Z","timestamp":1783922936992,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007194","name":"Wenzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["Y2023012"],"award-info":[{"award-number":["Y2023012"]}],"id":[{"id":"10.13039\/501100007194","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bcp.2026.118069","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:01:13Z","timestamp":1778860873000},"page":"118069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P1","title":["A novel hesperetin derivative DU12 targets cyclin-dependent kinase 17 (CDK17) to inhibit malignant progression of ovarian cancer"],"prefix":"10.1016","volume":"251","author":[{"given":"Chunyu","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bcp.2026.118069_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188503","article-title":"Roles of CA125 in diagnosis, prediction, and oncogenesis of ovarian cancer","volume":"1875","author":"Zhang","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bcp.2026.118069_b0010","doi-asserted-by":"crossref","unstructured":"M. Bates, B.M. Mohamed, F. Lewis, S. O'Toole, J.J. O'Leary, Biomarkers in high grade serous ovarian cancer. Biochim. Biophys. Acta Rev. Cancer. 2024;1879(6):189224. doi: 10.1016\/j.bbcan.2024.189224. Epub 2024 Nov 23. PMID: 39581234.","DOI":"10.1016\/j.bbcan.2024.189224"},{"issue":"13","key":"10.1016\/j.bcp.2026.118069_b0015","doi-asserted-by":"crossref","first-page":"5208","DOI":"10.7150\/ijbs.100355","article-title":"Deubiquitinases in ovarian cancer: role in drug resistance and tumor aggressiveness","volume":"20","author":"Beretta","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"10","key":"10.1016\/j.bcp.2026.118069_b0020","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev-animal-021419-084001","article-title":"Ovarian cancer: applications of chickens to humans","volume":"15","author":"Barua","year":"2022","journal-title":"Annu. Rev. Anim. Biosci."},{"issue":"2","key":"10.1016\/j.bcp.2026.118069_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.semperi.2025.152043","article-title":"Ovarian cancer in pregnancy","volume":"49","author":"Jorgensen","year":"2025","journal-title":"Semin. Perinatol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118069_b0030","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12943-025-02345-3","article-title":"A comprehensive overview of ovarian cancer stem cells: correlation with high recurrence rate, underlying mechanisms, and therapeutic opportunities","volume":"24","author":"Alizadeh","year":"2025","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2026.118069_b0035","first-page":"77","article-title":"Radiomics and radiogenomics: extracting more information from medical images for the diagnosis and prognostic prediction of ovarian cancer","volume":"11","author":"Zeng","year":"2024","journal-title":"Mil. Med. Res."},{"issue":"588","key":"10.1016\/j.bcp.2026.118069_b0040","article-title":"STING inhibitors sensitize platinum chemotherapy in ovarian cancer by inhibiting the CGAS-STING pathway in cancer-associated fibroblasts (CAFs)","volume":"28","author":"Liu","year":"2024","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.bcp.2026.118069_b0045","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a041336","article-title":"Harnessing antitumor immunity in ovarian cancer","volume":"14","author":"Kurnit","year":"2024","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"1","key":"10.1016\/j.bcp.2026.118069_b0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12929-024-01005-w","article-title":"Hesperetin activates CISD2 to attenuate senescence in human keratinocytes from an older person and rejuvenates naturally aged skin in mice","volume":"31","author":"Shen","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.bcp.2026.118069_b0055","doi-asserted-by":"crossref","unstructured":"W. Li, Z. Cai, F. Schindler, L. Afjehi-Sadat, B. Montsch, P. Heffeter, E.H. Heiss, W. Weckwerth. Elevated PINK1\/parkin-dependent mitophagy and boosted mitochondrial function mediate protection of HepG2 Cells from excess palmitic acid by hesperetin. J. Agric. Food Chem., 2024;72(23):13039-13053. doi: 10.1021\/acs.jafc.3c09132. Epub 2024 May 29. PMID: 38809522; PMCID: PMC11181321.","DOI":"10.1021\/acs.jafc.3c09132"},{"issue":"16","key":"10.1016\/j.bcp.2026.118069_b0060","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1080\/10408398.2021.1875979","article-title":"Hesperetin's health potential: moving from preclinical to clinical evidence and bioavailability issues, to upcoming strategies to overcome current limitations","volume":"62","author":"Salehi","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.bcp.2026.118069_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2024.106206","article-title":"Comprehensive review of Hesperetin: advancements in pharmacokinetics, pharmacological effects, and novel formulations","volume":"179","author":"Song","year":"2024","journal-title":"Fitoterapia"},{"issue":"4","key":"10.1016\/j.bcp.2026.118069_b0070","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/FJC.0000000000001210","article-title":"Hesperetin inhibits sphingosylphosphorylcholine-induced vascular smooth muscle contraction by regulating the Fyn\/Rho-kinase pathway","volume":"79","author":"Lu","year":"2022","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118069_b0075","doi-asserted-by":"crossref","unstructured":"Q. Lu, Y. Lai, H. Zhang, K. Ren, W. Liu, Y. An, J. Yao, H. Fan, Hesperetin inhibits TGF-\u03b21-induced migration and invasion of triple negative breast cancer MDA-MB-231 cells via suppressing Fyn\/Paxillin\/RhoA pathway. Integr. Cancer Ther., 2022;21:15347354221086900. doi: 10.1177\/15347354221086900. PMID: 35297710; PMCID: PMC8943303.","DOI":"10.1177\/15347354221086900"},{"key":"10.1016\/j.bcp.2026.118069_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104324","article-title":"Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: clinical trials, current impact, and future directions","volume":"196","author":"Gerosa","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"15","key":"10.1016\/j.bcp.2026.118069_b0085","doi-asserted-by":"crossref","first-page":"3298","DOI":"10.1158\/1078-0432.CCR-23-3110","article-title":"Anti-EGFR antibody-drug conjugate carrying an inhibitor targeting CDK restricts triple-negative breast cancer growth","volume":"30","author":"Cheung","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bcp.2026.118069_b0090","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.semcancer.2022.12.006","article-title":"CDK inhibitors from past to present: a new wave of cancer therapy","volume":"88","author":"Mughal","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bcp.2026.118069_b0095","doi-asserted-by":"crossref","unstructured":"D. Zhou, E. Tang, W. Wang, Y. Xiao, J. Huang, J. Liu, C. Zheng, K. Zhang, R. Hu, F. Wang, P. Xiong, X. Chu, W. Li, D. Liu, X. Zeng, D. Zheng, L. Wang, Y. Zheng, S. Zhang, Combined therapy with DR5-targeting antibody-drug conjugate and CDK inhibitors as a strategy for advanced colorectal cancer. Cell Rep. Med., 2025;6(6):102158. doi: 10.1016\/j.xcrm.2025.102158. Epub 2025 May 30. PMID: 40449480; PMCID: PMC12208337.","DOI":"10.1016\/j.xcrm.2025.102158"},{"key":"10.1016\/j.bcp.2026.118069_b0100","doi-asserted-by":"crossref","unstructured":"A. Bangera, F. Lubaba, A. Perunelly, Gopalakrishnan, P.B. Shivamurthy, R. Raju, P. Ramesh, An assembly of the global phosphoproteomic network of an underexplored kinase CDK17: possible implications in cell cycle regulation. DNA Cell Biol., 2026:10445498261433751. doi: 10.1177\/10445498261433751. Epub ahead of print. PMID: 41851027.","DOI":"10.1177\/10445498261433751"},{"issue":"4","key":"10.1016\/j.bcp.2026.118069_b0105","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00018-023-04756-1","article-title":"SEMA6C: a novel adhesion-independent FAK and YAP activator, required for cancer cell viability and growth","volume":"80","author":"Fard","year":"2023","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcp.2026.118069_b0110","doi-asserted-by":"crossref","unstructured":"S. Zhou, W. Yan, W. Shen, J. Cheng, Y. Xi, S. Yuan, F. Fu, T. Ding, A. Luo, S. Wang, Low expression of SEMA6C accelerates the primordial follicle activation in the neonatal mouse ovary. J. Cell Mol. Med., 2018;22(1):486-496. doi: 10.1111\/jcmm.13337. Epub 2017 Sep 7. PMID: 28881413; PMCID: PMC5742695.","DOI":"10.1111\/jcmm.13337"},{"issue":"5","key":"10.1016\/j.bcp.2026.118069_b0115","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.3390\/ijms23052608","article-title":"Semaphorin 6C suppresses proliferation of pancreatic cancer cells via inhibition of the AKT\/GSK3\/\u03b2-catenin\/cyclin D1 pathway","volume":"23","author":"Hung","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.bcp.2026.118069_b0120","doi-asserted-by":"crossref","first-page":"4934","DOI":"10.1002\/jcp.27294","article-title":"Suppression of SEMA6C promotes preantral follicles atresia with decreased cell junctions in mice ovaries","volume":"234","author":"Yan","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"14","key":"10.1016\/j.bcp.2026.118069_b0125","doi-asserted-by":"crossref","first-page":"736","DOI":"10.6026\/97320630009736","article-title":"Possible utilization of -1 Ribosomal frame shifting in the expression of a human SEMA6C isoform","volume":"9","author":"Huang","year":"2013","journal-title":"Bioinformation"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226004028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226004028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T05:31:18Z","timestamp":1783920678000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226004028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":25,"alternative-id":["S0006295226004028"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118069","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel hesperetin derivative DU12 targets cyclin-dependent kinase 17 (CDK17) to inhibit malignant progression of ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118069"}}